Stereoselective block of a human cardiac potassium channel (Kv1.5) by bupivacaine enantiomers
Authors:
- C. ValenzuelaCVC. Valenzuela
- E. DelpónEDE. Delpón
- M.M. TamkunMTM.M. Tamkun
- J. TamargoJTJ. Tamargo
- D.J. SnydersDSD.J. Snyders
- 1 August 1995
- journal article
- Published by Elsevier in Biophysical Journal
- Vol. 69 (2) , 418-427
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- The internal quaternary ammonium receptor site of Shaker potassium channelsNeuron, 1993
- Molecular Biology of the Voltage‐Gated Potassium Channels of the Cardiovascular SystemJournal of Cardiovascular Electrophysiology, 1993
- Binding affinity and stereoselectivity of local anesthetics in single batrachotoxin-activated Na+ channels.Journal of General Physiology, 1990
- The Effect of Magnesium Sulfate Administration on Cerebral and Cardiac Toxicity of Bupivacaine in DogsAnesthesiology, 1990
- Voltage-dependent gating of Shaker A-type potassium channels in Drosophila muscle.Journal of General Physiology, 1990
- Gating mechanism of a cloned potassium channel expressed in frog oocytes and mammalian cellsNeuron, 1990
- Bupivacaine is an effective potassium channel blocker in heartBiochimica et Biophysica Acta (BBA) - Biomembranes, 1988
- The Electro physiologic Actions of Lidocaine and Bupivacaine in the Isolated, Perfused Canine HeartAnesthesiology, 1988
- Activation of squid axon K+ channels. Ionic and gating current studies.Journal of General Physiology, 1985
- The Influence of Serum Potassium on the Cerebral and Cardiac Toxicity of Bupivacaine and LidocaineAnesthesiology, 1984